中文｜English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Volume 38 Issue 1
Jan.  2022
Turn off MathJax
Article Contents
Article Navigation >  Journal of Clinical Hepatology  > 2022  >  38(1): 78-80

An excerpt of APASL guidance on stopping nucleos(t)ide analogues in chronic hepatitis B patients (2021)

DOI: 10.3969/j.issn.1001-5256.2022.01.011

  • First Department of Liver Disease Center, Beijing YouAn Hospital, Capital Medical University, Beijing 100069, China

Research funding:

Capital Health Development Scientific Research Project (2020-1-2181);

YouAn Foundation of Liver Disease and AIDS (YNKTQN20180209);

YouAn Foundation of Liver Disease and AIDS (BJYAYY-2020CX-01);

YouAn Foundation of Liver Disease and AIDS (BJYAYY-2020ZQN-01);

Bethune Medical Science Research Foundation (SG095FN)

  • Received Date: 2021-12-06
  • Accepted Date: 2021-12-06
  • Published Date: 2022-01-20

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Tables(1)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (671) PDF downloads(201) Cited by()
    Proportional views
    Related
        

    The first journal specializing in hepatobiliary and pancreatic diseases in China

    Supervisor：Ministry of Education of the People's Republic of China

    Sponsor：Jilin University

    Academic Support: Chinese Society of Hepatology，Chinese Medical Association

    Address: 461 Xinjiang Road, Changchun

    Submit：0431-88782044

    Peer review：0431-88783542

    Email：lcgdb@vip.163.com

    About Journal

    Submission Guideline

    Journal Online

    Hepatobiliary College

    Guidelines

    YesterdayIP[]YesterdayPV[]TodayIP[]TodayPV[]Online[]

    Website Design © 2020 Editorial Board of Journal of Clinical Hepatology 吉ICP备10000617号-1 Supported by: Beijing Renhe Information Technology Co. Ltd  

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return